HW
HHS icon

Hancock Whitney’s Harte-Hanks HHS Stock Holding History

Hancock Whitney’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-22,249
Closed -$563 – 589
2016
Q1 		$563 Buy
22,249
+14,940
+204% +$459K 0.02% 431
2015
Q4 		$237K Sell
7,309
-3,708
-34% -$139K 0.01% 497
2015
Q3 		$389K Buy
11,017
+2,543
+30% +$115K 0.02% 463
2015
Q2 		$661K Hold
8,474
– – 0.03% 393
2015
Q1 		$661K Buy
8,474
+4,267
+101% +$330K 0.03% 393
2014
Q4 		$325K Sell
4,207
-1,092
-21% -$71.4K 0.01% 460
2014
Q3 		$338K Sell
5,299
-39
-0.7% -$2.65K 0.01% 450
2014
Q2 		$384K Buy
5,338
+15
+0.3% +$1.16K 0.01% 441
2014
Q1 		$470K Buy
5,323
+820
+18% +$63.8K 0.02% 397
2013
Q4 		$352K Buy
4,503
+596
+15% +$48.6K 0.01% 444
2013
Q3 		$345K Sell
3,907
-2,734
-41% -$250K 0.02% 414
2013
Q2 		$571K Buy
+6,641
New +$550K 0.03% 303

Other funds holding HHS

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hancock Whitney's HHS Position: Q2 2016 in Review

Hancock Whitney sold out of Harte-Hanks (HHS) in Q2 2016, closing a stake of 22,249 shares — an estimated $563 sold.

Hancock Whitney first reported a position in HHS in Q2 2013 and held it in 12 quarters. The position peaked at $661K in Q2 2015. 107 funds tracked by Wall St. Rank hold HHS as of Q2 2016.

  • Hancock Whitney reported no remaining Harte-Hanks position as of Q2 2016 after selling out during the quarter.
  • Hancock Whitney sold 22,249 Harte-Hanks shares in Q2 2016, an estimated $563.
  • Hancock Whitney first reported a position in Harte-Hanks in Q2 2013 and held it in 12 quarters.
  • Hancock Whitney's Harte-Hanks position peaked at $661K in Q2 2015.
  • 107 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2016.

Based on Hancock Whitney's 13F filing for Q2 2016, filed 9 Aug 2016.